Treatment of relapsed acute myelogeneous leukaemia with MLL/AF 6 fusion after stem cell transplantation by intensive reinduction followed by adoptive immunotherapy

Leukemia. 2005 Jul;19(7):1273-4; author reply 1275-6. doi: 10.1038/sj.leu.2403791.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / immunology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Chromosomes, Human, Pair 6 / genetics*
  • Female
  • Graft vs Host Disease / etiology
  • Humans
  • Immunotherapy, Adoptive*
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Leukemia, Myeloid, Acute / immunology
  • Male
  • Mycoses / etiology
  • Myeloid-Lymphoid Leukemia Protein
  • Oncogene Proteins, Fusion / genetics*
  • RNA, Messenger / genetics
  • Recurrence
  • Remission Induction
  • Stem Cell Transplantation*

Substances

  • MLL-AF6 fusion protein, human
  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • Myeloid-Lymphoid Leukemia Protein